icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Characterization of HCV Resistance From a 3-Day Monotherapy Study
of GS-9857, a Novel Pangenotypic NS3/4A Protease Inhibitor

 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Eric Lawitz,1 Hadas Dvory-Sobol,2 Jenny C. Yang,2 Luisa M. Stamm,2 James G. Taylor,2 Diana M. Brainard,2 Michael D. Miller,2 Hongmei Mo,2 Maribel Rodriguez-Torres3
1Alamo Medical Research, San Antonio, TX; 2Gilead Sciences, Inc., Foster City, CA; 3Fundación de Investigación, Rio Pedras, Puerto Rico

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif